Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Upload two documents: Your itemized receipt from PureHealth Research Your Letter of Medical Necessity from Flex *Flex eligibility and approval are required
Age-related NAD+ decline
Protocol 2: the tirzepatide micro-step escalation Goal: Avoid the dramatic side effects common with standard 2.5 mg escalation jumps Schedule (compounded tirzepatide required): Weeks 1-4: 2.5 mg weekly Weeks 5-8: 3.0 mg weekly Weeks 9-12: 3.75 mg weekly Weeks 13-16: 5.0 mg weekly Weeks 17-20: 6.25 mg weekly Weeks 21-24: 7.5 mg weekly Continue escalating by 1.25-2.5 mg every 4 weeks as needed Why the plotter supports this: The standard jump from 2.5 mg to 5 mg produces a transition spike where your first-week peak at 5 mg can exceed the eventual 5 mg steady-state peak by 15-25%
Their provider recommends moving to tirzepatide to push through
US$ 23.87
US$ 29.42
US$ 29.82
